The Preventive and Therapeutic Effects of Aronox Extract on Metabolic Abnormality and Hypertension.
10.5646/jksh.2011.17.3.95
- Author:
Young Mee PARK
1
;
Jeong Bae PARK
Author Information
1. Samsung Biomedical Research Institute, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Aronia melanocarpa;
Hypertension;
Glucose;
Spontaneously hypertensive rats
- MeSH:
Amlodipine;
Atherosclerosis;
Blood Pressure;
Body Weight;
Collagen;
Fasting;
Fibrosis;
Functional Food;
Glucose;
Heart;
Humans;
Hypertension;
Kidney;
Male;
Photinia;
Rats, Inbred SHR;
Salicylamides;
Tail
- From:Journal of the Korean Society of Hypertension
2011;17(3):95-102
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Aronox is an anthocyanin-rich extract from Aronia melanocarpa E which is known to have anti-inflammatory effect in atherosclerosis due to high anti-oxidative activity. This study was conducted to evaluate the preventive and therapeutic effect of Aronox on hypertension and metabolic status in spontaneously hypertensive rats (SHR). METHODS: Seven-week-old male SHR were orally administrated with Aronox (low dose; 100 mg/kg, n = 4 or high dose; 200 mg/kg, n = 3) or amlodipine (10 mg/kg, n = 7) and sham (n = 10) for 8 weeks. Aronox was administered 30 mg/kg for the first 3 weeks and then increased to 100 mg/kg (low dose group) or 100 mg/kg to 200 mg/kg (high dose group). Systolic blood pressure (SBP) was measured every week by tail cuff method. At 8 weeks, fasting lipid level was measured. Heart and kidney stained with Masson's trichrome. RESULTS: Aronox or amlodipine treatment showed significantly lower SBP compared with sham (202.2 +/- 10.2 mm Hg in low dose group, 202.0 +/- 12.6 mm Hg in high dose group and 187.4 +/- 22.7 mm Hg in amlodipine group vs. 224.4 +/- 12 mm Hg in sham-SHR, p < 0.005). There were no significant differences in cardiac and renal weight corrected by body weight among 3 groups. Aronox and amlodipine treatments significantly decreased fasting glucose and showed a trend of decrease in triglyceride level. Aronox or amlodipine treatment for 8 weeks showed less collagen deposition changes compared to sham. CONCLUSIONS: Aronox showed significant antihypertensive effects, decreased fasting glucose, and less cardiac and renal fibrosis in SHR. These results suggest that Aronox can be used as an adjuvant therapy or functional food in hypertension.
